Unfortunate Medlab would want to 'cap' themselves at a Market cap of 80mill$.
BOT=$130mill
MXC=$180mill
CAN=$200mill
CPH=$218mill
MDC having most advanced medical cannabis clinical trials and backing (HOA's) by several billion dollar pharmaceutical companies positioned in Aus, Canada, Thailand and US... $80million capping is questionable and suspiciously low.
Unfortunate Medlab would want to 'cap' themselves at a Market...
Add to My Watchlist
What is My Watchlist?